Sogroya האיחוד האירופי - איסלנדית - EMA (European Medicines Agency)

sogroya

novo nordisk a/s - somapacitan - vöxtur - hinsveiflur og heilahimnubólur og hliðstæður - sogroya is indicated for the replacement of endogenous growth hormone (gh) in children  aged 3  years and above, and adolescents with growth failure due to growth hormone deficiency (paediatric ghd), and in adults with growth hormone deficiency (adult ghd).

Wegovy האיחוד האירופי - איסלנדית - EMA (European Medicines Agency)

wegovy

novo nordisk a/s - semaglútíð - obesity; overweight - Ónæmiskerfi, þó ekki mataræði - wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial body mass index (bmi) of- ≥30 kg/m² (obesity), or- ≥27 kg/m² to.

Trisekvens Filmuhúðuð tafla איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

trisekvens filmuhúðuð tafla

novo nordisk a/s* - estradiol; norethisteronum acetat - filmuhúðuð tafla

Kliogest Filmuhúðuð tafla איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

kliogest filmuhúðuð tafla

novo nordisk a/s* - norethisteronum acetat; estradiol - filmuhúðuð tafla

Novofem Filmuhúðuð tafla איסלנד - איסלנדית - LYFJASTOFNUN (Icelandic Medicines Agency)

novofem filmuhúðuð tafla

novo nordisk a/s* - estradiol; norethisteronum acetat - filmuhúðuð tafla